Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
 FDG PET Scan Meaning and Its Role in Modern Cancer Oncology
FDG PET Scan Meaning and Its Role in Modern Cancer Oncology 3

Cancer diagnosis has changed a lot with new imaging tools. The FDG PET scan is key in oncology. But what does FDG mean here?

FDG is short for fluorodeoxyglucose. It’s a sugar molecule cancer cells use. The FDG PET scan finds where this molecule is in the body. This helps doctors spot cancer cells and figure out how far the cancer has spread.

Key Takeaways

  • FDG stands for fluorodeoxyglucose, a compound used in PET scans.
  • The FDG PET scan is a critical tool in oncology for cancer diagnosis.
  • It helps in identifying cancerous cells by detecting the uptake of fluorodeoxyglucose.
  • FDG PET scans are used to diagnose and stage cancer.
  • The use of FDG in PET scans has revolutionized cancer management.

Understanding FDG: The Basics of Fluorodeoxyglucose

FDG, or fluorodeoxyglucose, is a special glucose molecule used in PET scans. It’s made to be taken up by cells, mainly those that use a lot of glucose, like cancer cells.

Chemical Structure and Properties of FDG

FDG is a synthetic glucose analog. It has a hydrogen atom instead of a hydroxyl group on the second carbon atom. This change stops FDG from being broken down after it enters cells, making it detectable in PET scans.

Its structure is close to glucose, allowing it to enter cells through glucose transporters. Inside, hexokinase phosphorylates it, starting glucose metabolism. But, unlike glucose, FDG-6-phosphate can’t move further and gets stuck in the cell.

How FDG Mimics Glucose in the Body

FDG acts like glucose in the body by using the same uptake pathways. Cancer cells, with their high glucose use, take up more FDG than normal cells. This makes FDG a great tracer for finding cancer during PET scans.

  • FDG is taken up by cells via glucose transporters.
  • It’s phosphorylated by hexokinase, trapping it inside the cell.
  • Cancer cells with high metabolic rates accumulate more FDG.

FDG Medical Abbreviation Explained

The medical term FDG stands for Fluorodeoxyglucose. It’s a radioactive tracer used in PET scans to check metabolic activity in the body. In oncology, FDG is key for seeing and checking tumor activity.

Knowing how FDG works in glucose metabolism and PET scans is key for understanding imaging results. It helps doctors see how active tissues are, helping in diagnosing, staging, and tracking cancer.

The Science Behind FDG PET Scan Technology

 FDG PET Scan Meaning and Its Role in Modern Cancer Oncology
FDG PET Scan Meaning and Its Role in Modern Cancer Oncology 4

Understanding FDG PET scans is key to seeing their value in fighting cancer. These scans are vital in diagnosing and planning treatment for cancer. They show how active cells are in the body.

Principles of Positron Emission Tomography

PET scans use nuclear medicine to find positrons from radioactive tracers. These tracers go to active areas, like cancer cells. When they decay, they release positrons that create gamma rays.

The PET scanner catches these gamma rays to make detailed images. These images show how active different parts of the body are. This helps doctors see where disease is and how far it has spread.

Role of Radioactive Tracers in Imaging

Radioactive tracers are the core of PET scans. The most used one is Fluorodeoxyglucose (FDG). It’s like glucose that cancer cells take up more of because they’re more active.

Doctors pick the right tracer for each case. For example, FDG is best for finding cancer. New tracers are being made to help with other health issues too.

TracerApplicationCharacteristics
FDGOncologyGlucose analog, accumulates in areas of high glucose metabolism
FlortaucipirNeurologyBinds to tau protein, used in Alzheimer’s disease diagnosis
Rubidium-82CardiologyUsed for myocardial perfusion imaging

What Does PET Scan Stand For?

PET scan stands for Positron Emission Tomography. It’s a way to see how the body works. By using tracers and detecting positrons, PET scans give a unique look at the body’s function.

When PET scans are used with CT or MRI, they become even more powerful. This is because they can show both how active cells are and where they are in the body at the same time.

Historical Development of FDG in Medical Imaging

The use of FDG in medical imaging was a big step forward in nuclear medicine. It has become key in finding and treating many cancers.

Early Research and Discoveries

Studies showed FDG could show where glucose was being used a lot. This was important for finding cancer. It highlighted areas with high activity.

Evolution of FDG-PET Technology

FDG-PET technology has grown a lot. Better scanners and new ways to make images have helped. Now, we can find and understand cancers better.

YearMilestone
1970sSynthesis of FDG
1980sFirst human PET scans using FDG
1990sWidespread adoption of FDG-PET in oncology

Milestones in Clinical Implementation

FDG-PET has become a big part of cancer care. It’s used to find, understand, and track cancer. It’s now a standard tool in oncology.

Key milestones include:

  • Inclusion in clinical guidelines for various cancers
  • Advancements in PET-CT fusion imaging

The history of FDG in medical imaging shows its big role in healthcare today. As technology gets better, FDG-PET will help us learn more about cancer and how to treat it.

How FDG PET Scans Work in Oncology

FDG PET scans have changed how we diagnose cancer. They show how tumors work by looking at their metabolism. This is key in cancer treatment, as it helps doctors decide the best course of action.

Cancer Cells and Glucose Metabolism

Cancer cells use glucose differently than healthy cells. This is called the Warburg effect. They use more glucose, which FDG PET scans can spot.

FDG is a glucose-like substance that cancer cells take up more of. This makes cancer cells stand out on a PET scan.

Detecting Metabolic Activity in Tumors

FDG PET scans are great for finding tumors because of their high metabolism. They show where cancer cells are and how active they are.

This info is vital for diagnosing cancer, figuring out how far it has spread, and checking how well treatments work. Tumors that use a lot of glucose might be more aggressive. If a tumor uses less glucose after treatment, it’s a good sign.

Visualizing Cancer Through FDG Uptake

How much FDG a tumor takes up is important for seeing cancer on PET scans. This is measured by Standardized Uptake Values (SUV). It shows how active the tumor is.

Seeing cancer through FDG uptake helps doctors diagnose and plan treatment. It guides biopsies and decides if treatment needs to be stronger.

FDG Avidity Meaning in Cancer Diagnosis

FDG avidity shows how much cancer cells take up FDG. High avidity means the tumor is very active, which might mean it’s more aggressive.

Knowing about FDG avidity is key in diagnosing cancer. It helps doctors figure out the risk and plan treatment. Tumors with high avidity might need more intense treatment.

CharacteristicsHigh FDG AvidityLow FDG Avidity
Metabolic ActivityHighLow
Cancer AggressivenessMore AggressiveLess Aggressive
Treatment ApproachMore IntensiveLess Intensive

The Complete FDG PET Scan Procedure

For those with cancer, knowing about the FDG PET scan can ease worries. It’s a key tool for diagnosing, staging, and tracking cancer treatment.

Patient Preparation and Requirements

Getting ready for a FDG PET scan is important. Patients usually need to fast for 4-6 hours before. This lowers blood sugar, making the scan more accurate.

They should also avoid hard exercise for 24 hours beforehand. This stops muscles from taking up too much glucose.

Telling your doctor about any meds or health issues is also key. Diabetics must manage their blood sugar closely before the scan.

The Injection Process

The scan starts with an FDG injection into a vein. This tracer goes to active cells, like tumors, making them stand out.

The injection is mostly painless. The radiation dose is kept low to ensure safety while getting good images.

The Scanning Experience

After the injection, patients wait 60-90 minutes for the FDG to spread. They should rest quietly to avoid muscle activity.

The scan involves lying on a table that slides into a PET scanner. The scan is painless and lasts about 30-60 minutes. It’s important to stay very quiet to get clear images.

Post-Scan Protocols

After the scan, patients can go back to their usual activities. Drinking lots of water helps get rid of the tracer.

It’s wise for patients to stay away from pregnant women and young kids for a bit. This is because of the small amount of radiation.

Benefits of FDG PET Scan for Cancer Detection

FDG PET scans have changed how we find cancer. They show how active tumors are. This has made diagnosing cancer more accurate and complete.

Early Detection Capabilities

FDG PET scans are great at finding cancer early. They spot tumors by their high activity. This is before symptoms or other scans can see them.

Early detection is key. It lets doctors start treatment sooner. This can lead to better results. These scans find cancer changes early, helping everyone involved.

Whole-Body Assessment in One Procedure

FDG PET scans can look at the whole body at once. This helps doctors see how far cancer has spread. It’s important for planning treatment.

This single scan makes diagnosis easier. It means fewer tests for patients. It also saves money for healthcare.

Imaging ModalityArea AssessedInformation Provided
FDG PET ScanWhole BodyMetabolic Activity
CT ScanSpecific RegionAnatomical Detail
MRISpecific RegionDetailed Soft Tissue Imaging

Metabolic Information vs. Anatomical Imaging

FDG PET scans look at how cells work, not just their shape. This is important because cancer changes cell function first. Then, it changes shape.

By using both metabolic and anatomical info, doctors get a full picture. This helps them plan better treatments.

Interpreting FDG PET Scan Results

When we look at FDG PET scans, we focus on SUV values and what high FDG uptake means. Getting these results right is key for finding and treating cancer.

Understanding SUV Values

SUV, or Standardized Uptake Value, shows how much FDG is taken up by tissues. It tells us about the activity of tumors. We calculate SUV by comparing the activity in a specific area to the dose and body weight.

SUV Value RangeInterpretation
0-2.5Typically considered normal or low metabolic activity
2.5-4.0May indicate mild to moderate metabolic activity
>4.0Often associated with high metabolic activity, potentially malignant

What High FDG Uptake Indicates

High FDG uptake usually means tissues are very active, like cancer. But, it can also show up in inflammation or benign conditions.

False Positives and Negatives

FDG PET scans can sometimes show false positives or false negatives. False positives happen when non-cancerous conditions look like cancer. False negatives occur when cancer is missed because it’s not very active.

  • Things like how well the patient is prepared, the scanner’s sensitivity, and the interpreter’s skill can affect these results.
  • Knowing these can help doctors make better choices for patients.

Understanding SUV values, what high FDG uptake means, and the chance for false results helps doctors make better decisions for their patients.

Clinical Applications of FDG-PET Imaging in Cancer Care

FDG-PET imaging gives detailed metabolic info, making it key in cancer care. It’s used from the start of diagnosis to tracking treatment and follow-ups. This makes it a vital tool in cancer management.

Cancer Diagnosis and Staging

FDG-PET imaging is vital for cancer diagnosis and staging. It spots high metabolic activity, showing cancerous tissues. This info is key for knowing the cancer stage, which guides treatment.

Treatment Planning and Monitoring

In treatment planning, FDG-PET imaging offers insights into tumor activity. This helps doctors plan targeted treatments. During treatment, scans track how tumors respond, guiding treatment changes.

Detecting Recurrence

FDG-PET imaging is great at spotting cancer return early. It catches metabolic changes linked to recurrence before anatomical signs appear.

Response Assessment During Therapy

Assessing therapy response is another FDG-PET imaging use. It checks tumor activity changes during treatment. This helps doctors decide if treatment should continue or change.

ApplicationDescriptionBenefits
Cancer Diagnosis and StagingIdentifies cancerous tissues and determines the stage of cancerAccurate staging for appropriate treatment planning
Treatment Planning and MonitoringProvides insights into tumor metabolic activityTargeted treatment strategies and monitoring of treatment response
Detecting RecurrenceIdentifies early signs of cancer recurrenceEarly intervention for improved outcomes
Response Assessment During TherapyEvaluates changes in tumor metabolic activity during treatmentInformed decisions about treatment continuation or modification

FDG PET Scan vs. Other Imaging Modalities

In oncology, imaging tools like FDG PET scans, CT scans, and MRI have their own strengths. They are used for different purposes.

Comparison with CT Scans

CT scans show detailed body structures. On the other hand, FDG PET scans provide metabolic information. This means CT scans are great for finding structural issues. But, FDG PET scans can spot cancer cells’ metabolic activity.

  • FDG PET scans are better at finding cancer in lymph nodes and distant organs.
  • CT scans are better for precise body part locations.

Comparison with MRI

MRI gives detailed images of soft tissues, which is key for some cancer diagnoses. Yet, FDG PET scans are better at showing tumor metabolic activity across the body.

  1. MRI is great for the brain, spine, and soft tissues.
  2. FDG PET scans are top for finding active cancer cells anywhere.

Benefits of PET-CT Fusion Imaging

PET-CT fusion imaging combines PET and CT for both metabolic and anatomical info in one scan. This fusion boosts diagnostic accuracy. It’s very useful for:

  • Finding tumors’ exact location.
  • Helping with biopsies and treatments.

FDG PET Scan vs. DOTATATE PET Scan

DOTATATE PET scans focus on neuroendocrine tumors with a specific tracer. FDG PET scans are more general, detecting many cancers by glucose use. DOTATATE PET scans, though, are more specific for certain tumors.

Imaging ModalityPrimary UseKey Benefit
FDG PET ScanGeneral cancer diagnosis and stagingDetects metabolic activity
DOTATATE PET ScanNeuroendocrine tumorsHigh specificity for certain tumors

Preparing for Your FDG PET Scan: Diet and Guidelines

Knowing how to prepare for an FDG PET scan is key. It helps get accurate results. Proper prep is essential.

Dietary Restrictions Before the Scan

Your diet is important before an FDG PET scan. You’ll likely be told to eat a low-carb, high-fat diet. This helps show tumors better by reducing glucose in normal tissues.

Avoid sugary foods and drinks the day before and the day of the scan. No sugary drinks, candy, or foods like bread and pasta.

Sample Menu Before PET Scan

Before a PET scan, eat foods low in carbs but high in fat and protein. Here are some examples:

MealFood Items
BreakfastScrambled eggs with spinach, avocado
LunchGrilled chicken breast with olive oil, green salad
DinnerBaked salmon with cauliflower rice, butter

Medication Considerations

Some meds can change how an FDG PET scan works. Tell your doctor about all meds, including vitamins and supplements.

Some meds might need to be changed or stopped before the scan. Your doctor will tell you what to do based on your meds.

Physical Activity Guidelines

Exercise can affect where FDG goes in your body. Try to avoid hard exercise before the scan. It can make muscles look like tumors.

But, you can usually keep up with your daily activities unless your doctor says not to.

Potential Risks and Side Effects of FDG PET Scans

FDG PET scans are generally safe, but they can have risks and side effects. It’s important for patients to know about these to make informed choices.

Radiation Exposure Concerns

One major concern is radiation exposure. The scan uses a radioactive tracer that emits radiation. This is a big deal, mainly for those needing many scans or with other risk factors.

  • The effective dose from a typical FDG PET scan is about 7-10 mSv.
  • Younger patients and those exposed to radiation before face higher risks.
  • Talk to your doctor about your specific risks.

Common Side Effects

Most people find FDG PET scans okay, but some might feel side effects. These can include:

  1. Discomfort or pain where the injection was given.
  2. Allergic reactions to the tracer (very rare).
  3. A metallic taste during or after the injection.

Most side effects are mild and go away on their own without treatment.

Safety Considerations for Special Populations

Some groups need extra care with FDG PET scans. These include:

  • Pregnant or breastfeeding women, due to risks to the fetus or baby.
  • Patients with diabetes, as it can affect how FDG is taken up.
  • People with claustrophobia, who might need extra help or sedation.

Tell your doctor about any health issues or concerns before the scan.

Conclusion: The Future of FDG in Cancer Diagnosis and Treatment

FDG has changed how we diagnose and treat cancer. It helps find cancer early and plan treatments better. This is because FDG PET scans show how cancer cells use glucose.

Looking ahead, FDG’s role in cancer care is set to grow. New research and better PET technology are on the horizon. This means better images and more access to FDG PET scans. It will help doctors diagnose and treat cancer more effectively.

FDG is key in the battle against cancer now and will be in the future. Its growth and use will be essential. It will help improve how we diagnose, treat, and care for cancer patients. This will shape the future of cancer care.

FAQ

What is FDG and how is it used in oncology?

FDG, or Fluorodeoxyglucose, is a radioactive tracer used in PET scans. It helps find cancerous tissues by mimicking glucose in the body.

What does PET scan stand for?

PET scan stands for Positron Emission Tomography scan. It’s a medical imaging technique that uses radioactive tracers to see metabolic activity in the body.

How does FDG PET scan work?

FDG PET scan works by injecting FDG into the body. Cancer cells, with their high metabolic rates, absorb more FDG. This lets the PET scan detect and see tumors based on their metabolic activity.

What is the significance of FDG avidity in cancer diagnosis?

FDG avidity shows how much cancer cells take up FDG. High FDG avidity means high metabolic activity, often seen in aggressive cancer. It helps in diagnosing and staging cancer.

How should I prepare for an FDG PET scan?

To prepare for an FDG PET scan, avoid sugary foods and drinks. You might need to fast for a while. Also, follow guidelines on medications and physical activity.

What are the benefits of FDG PET scans in cancer detection?

FDG PET scans can detect cancer early and assess the whole body. They provide metabolic information that anatomical imaging can’t. This makes them valuable for detecting, staging, and monitoring treatment response.

How do FDG PET scan results get interpreted?

Interpreting FDG PET scan results involves looking at SUV measurements. High SUV values often suggest cancerous activity. But, it’s important to consider false positives and negatives.

What are the possible risks and side effects of FDG PET scans?

Risks include radiation exposure, but it’s usually safe. Common side effects are rare but can include reactions to the FDG injection. Pregnant or breastfeeding women should talk to their healthcare provider about safety.

How does FDG PET scan compare to other imaging modalities like CT or MRI?

FDG PET scans offer metabolic information that complements CT or MRI anatomical imaging. PET-CT fusion imaging combines both, providing detailed metabolic and anatomical data. The choice depends on the clinical question and patient needs.

What is the difference between FDG PET scan and DOTATATE PET scan?

FDG PET scan is used for many cancers, detecting tumors based on glucose metabolism. DOTATATE PET scan is for neuroendocrine tumors, targeting somatostatin receptors. The choice depends on the type of cancer being evaluated.

Reference

  1. Boellaard, R., Delgado‐Bolton, R., Oyen, W. J. G., Giammarile, F., Tatsch, K., Eschner, W., & Krause, B. J. (2015). FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. European Journal of Nuclear Medicine and Molecular Imaging, 42(2), 328–354. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315529/

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 26 75